Tonix Pharmaceuticals (TNXP) Stock: Gaining On Patient Enrollment

Tonix Pharmaceuticals TNXP Stock News

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) is flying early on in the trading session this morning, and for good reason. The company announced its first patient enrollment in a Phase 3 clinical trial. Of course, the news excited investors who are pushing the stock on a run for the top. Today, we’ll talk about: The … Read more

Ritter Pharmaceuticals (RTTR) Stock: Climbing On Phase 3 Enrollment News

Ritter Pharmaceuticals RTTR Stock News

Ritter Pharmaceuticals Inc (NASDAQ: RTTR) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced that it has completed enrollment in a key Phase 3 clinical trial. As you could imagine, the news excited investors, pushing the stock on a run for the top. Today, we’ll … Read more

BioPharmX (BPMX) Stock: Climbing On Trial Enrollment

BioPharmX BPMX Stock News

BioPharmX Corp (NYSEAMERICAN: BPMX) is climbing in the market this morning, and for good reason. The comapny announced news with regard to trial enrollment, exciting investors and sending the stock for the top. Today, we’ll talk about: The trial enrollment news; what we’re seeing from BPMX stock as a result; and what we’ll be watching … Read more